A Call for Vaccine Against COVID-19: Implications for Cardiovascular Morbidity and Healthcare Utilization

Cardiovasc Drugs Ther. 2020 Aug;34(4):585-587. doi: 10.1007/s10557-020-06985-z.
No abstract available

Publication types

  • Letter

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Cardiology Service, Hospital* / organization & administration
  • Cardiology Service, Hospital* / trends
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / prevention & control
  • Change Management
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / therapy
  • Drug Development*
  • Humans
  • Infection Control / organization & administration
  • Pandemics / prevention & control*
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / therapy
  • SARS-CoV-2
  • Vaccination / methods